Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.96 HKD | +2.05% | +2.05% | -10.78% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.78% | 517M | |
+26.56% | 659B | |
+26.74% | 557B | |
-5.22% | 359B | |
+16.98% | 322B | |
+9.19% | 297B | |
+6.13% | 215B | |
+4.95% | 210B | |
-6.01% | 200B | |
-8.25% | 149B |
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics
- Ocumension Therapeutics : Acquires Three Million Shares of EyePoint Pharmaceuticals